3D Conformal Radiation Therapy with Reduced Tissue Stress and Improved Positional Tolerance
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 62/526,548, filed Jun 29, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,496,466 | Simulation-Based Drug Treatment Planning In force · High confidence | Insightec, Ltd. | In force | High confidence | ||
| US 11,123,575 | 3D Conformal Radiation Therapy with Reduced Tissue Stress and Improved Positional Tolerance In force · High confidence | Insightec, Ltd. | In force | High confidence | ||
| US 11,857,807 | Simulation-Based Drug Treatment Planning In force · High confidence | Insightec, Ltd. | In force | High confidence | ||
| US 11,938,343 | Cavitation-Enhanced Targeted Drug Delivery and Dosing In force · High confidence | Insightec, Ltd. | In force | High confidence |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.